MedTrace Logo

Intrauterine G-CSF Administration in RIF

NCT03783208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2018-12-24

No results posted yet for this study

Summary

Aim of this study is to investigate the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group

Conditions

Interventions

DRUG

G-CSF

Slow infusion of G-CSF into the endometrial cavity using a soft embryo transfer catheter.

OTHER

Saline

Slow infusion of saline into the endometrial cavity using a soft embryo transfer catheter.

Sponsors & Collaborators

  • Gurgan Clinic

    lead NETWORK

Principal Investigators

  • Ziya Kalem, MD · Gurgan Clinic IVF and Women Health Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2018-12-20
Completion
2018-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03783208 on ClinicalTrials.gov